Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,166,218
-$1,339,968 QoQ
Shares Held
297,024
+28.5% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $679,878,666 across 12 Drug Manufacturers - Specialty & Generic names. HIMS ranks #9 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,948,745 | $466,781,145 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,664,458 | $50,133,474 | |
| 3 | HLN |
Haleon plc
|
4,639,437 | $46,440,764 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,260,104 | $41,857,126 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
931,364 | $22,287,540 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
34,287 | $20,331,504 | |
| 7 | VTRS |
Viatris Inc
|
881,323 | $11,906,673 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
89,059 | $11,732,631 |
All Filings in HIMS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,166,218 | 297,024 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,506,186 | 231,173 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,651,365 | 205,419 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,293,434 | 186,428 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,990,280 | 67,353 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $86,129 | 3,562 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $70,659 | 3,836 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $110,721 | 5,484 | Shares | Defined | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||